ADVANCED SOLID TUMOURS
Clinical trials for ADVANCED SOLID TUMOURS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID TUMOURS trials appear
Sign up with your email to follow new studies for ADVANCED SOLID TUMOURS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human test of new pill targets 'Undruggable' cancer mutation
Disease control TerminatedThis early-stage study tested a new oral drug, AZD0022, alone and combined with another cancer drug, in people with advanced solid tumors driven by a specific genetic change called KRASG12D. The main goals were to find a safe dose and see if the treatment caused any side effects.…
Matched conditions: ADVANCED SOLID TUMOURS
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Radioactive bullet targets advanced cancers in early trial
Disease control TerminatedThis early-stage study tested a new radioactive drug designed to target and destroy advanced solid tumors. It involved 78 patients with various cancers who had run out of standard treatment options. The main goals were to check the treatment's safety, find the right dose, and see…
Matched conditions: ADVANCED SOLID TUMOURS
Phase: PHASE1 • Sponsor: Fusion Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Terminated early: cancer drug interaction trial ends after one patient
Knowledge-focused TerminatedThis early-stage study aimed to understand how a cancer drug called ceralasertib changes the way the body processes three other cancer drugs. It was designed for a small group of adults with advanced solid tumors. The study was terminated after enrolling only one participant.
Matched conditions: ADVANCED SOLID TUMOURS
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:41 UTC